.svg){kind=small}
Oct-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
In Illinois, Remedi has shown a consistent presence in the Concentrates category, maintaining a position within the top 30 brands. From July to October 2025, the brand fluctuated slightly, rising from 22nd to 21st place, then dropping to 24th before returning to 21st. This steady performance suggests a stable consumer base, although sales figures indicate some volatility, with a notable dip in September. In contrast, Remedi's performance in the Tincture & Sublingual category has been more robust, consistently ranking in the top three until October, when it slipped to fourth place. This category appears to be a stronghold for Remedi in Illinois, despite the recent ranking decline.
In Massachusetts, Remedi's journey in the Concentrates category has been more erratic. Starting outside the top 30 in July, the brand made a significant leap to 26th place in August, but this momentum was not sustained, with rankings slipping to 31st and then 39th by October. This indicates a struggle to maintain a competitive edge in Massachusetts, contrasting with their relatively stable performance in Illinois. The fluctuations in Massachusetts suggest there may be underlying challenges or opportunities in the market that Remedi could address to improve its standing.
Competitive Landscape
In the competitive landscape of concentrates in Illinois, Remedi has shown a fluctuating yet promising trajectory in terms of rank and sales. Over the months from July to October 2025, Remedi's rank has seen a slight improvement, moving from 22nd to 21st, indicating a potential upward trend. This is noteworthy as competitors like Dabstract and Avexia have experienced declines, with Dabstract dropping out of the top 20 by October and Avexia consistently ranking lower. Meanwhile, nuEra has shown a more volatile pattern, bouncing back to 18th place in October after a dip. Despite Remedi's lower sales figures compared to these competitors, its consistent rank improvement suggests a strengthening market position, potentially driven by strategic marketing or product differentiation. This trend positions Remedi as a brand to watch, as it could capitalize on the instability of its competitors to gain a stronger foothold in the Illinois concentrates market.
Notable Products
In October 2025, the top-performing product for Remedi was the Indica Relief RSO Syringe (0.5g) in the Concentrates category, maintaining its consistent first-place ranking from the previous months with sales of 1777. The Indica Rest RSO Dropper (0.5g) also held steady at second place in the same category. The Indica Rest RSO Syringe (0.5g) continued its stable performance, maintaining the third position. The CBD/THC 1:1 Relief Tincture (50mg CBD, 50mg THC, 30ml) climbed to fourth place, up from its consistent fifth position in prior months. Notably, the Tropicanna Banana RSO Dropper (1g) debuted in fifth place in October, marking its entry into the rankings.
```Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
